rs10971170 (Y_RNA-APTX): IgG Glycosylation Variant

Q: What is rs10971170 associated with?

rs10971170 is located in the Y_RNA-APTX region and was identified in a genome-wide association study of IgG antibody glycosylation, the process of attaching sugar chains to antibodies. The broader set of loci in this study overlaps with genes previously linked to autoimmune conditions and blood cancers, though specific data for this variant alone is limited.

Q: What is IgG glycosylation and why does it matter?

IgG glycosylation refers to the attachment of sugar chains (glycans) to IgG antibodies. These sugar structures influence how antibodies interact with immune receptors, for example, the absence of galactose is linked to rheumatoid arthritis, and the addition of sialic acid can convert IgG from a pro-inflammatory to an anti-inflammatory signal.

Q: What does the APTX gene do?

APTX encodes aprataxin, a protein involved in DNA repair. The rs10971170 variant sits in the genomic neighborhood of APTX and a small non-coding RNA element called Y_RNA, though the study providing this association does not describe a direct functional role for these elements in IgG glycosylation.

Q: Is rs10971170 linked to autoimmune disease?

The study found that several genetic loci associated with IgG glycosylation overlap with regions previously linked to autoimmune diseases including lupus, rheumatoid arthritis, and multiple sclerosis. Whether this applies directly to this variant is not specified in the available study data.

Q: How reliable is the evidence for rs10971170?

The source study used a large combined sample of roughly 4,100 Europeans and two independent laboratory methods with a strict significance threshold. However, this variant is not named among the principal loci in the study abstract, and per-variant data is not available from the provided text, so the strength of evidence for this specific variant is uncertain.

rs10971170 (Y_RNA-APTX): IgG Glycosylation Variant

Key takeaways

This variant was identified in a genome-wide study of sugar-chain patterns on IgG antibodies in roughly 4,100 Europeans.
IgG glycosylation controls whether antibodies promote or suppress inflammation, making it a key part of immune regulation.
Loci from this study overlap with genes previously linked to lupus, rheumatoid arthritis, and blood cancers.
Specific effect size and glycan trait data for this variant are not available from the provided study text.
Evidence is preliminary, with this variant's individual associations not yet confirmed in independent replication.

Key takeaways

This variant was identified in a genome-wide study of sugar-chain patterns on IgG antibodies in roughly 4,100 Europeans.
IgG glycosylation controls whether antibodies promote or suppress inflammation, making it a key part of immune regulation.
Loci from this study overlap with genes previously linked to lupus, rheumatoid arthritis, and blood cancers.
Specific effect size and glycan trait data for this variant are not available from the provided study text.
Evidence is preliminary, with this variant's individual associations not yet confirmed in independent replication.

What the research says A genome-wide association study measured 77 quantitative N-glycosylation traits on IgG antibodies using ultra-performance liquid chromatography in a discovery sample of 2,247 Europeans from four populations, identifying 9 loci at genome-wide significance (P < 2.27 x 10^-9). Two of those loci (B4GALT1 and MGAT3) were independently replicated in 1,848 additional Europeans using MALDI-TOF mass spectrometry, a second and independent laboratory method. The authors reported that beyond the four glycosyltransferase genes identified, the remaining loci overlap substantially with genes previously linked to autoimmune and inflammatory conditions such as systemic lupus erythematosus, rheumatoid arthritis, and Crohn's disease, as well as haematological cancers including acute lymphoblastic leukaemia and Hodgkin lymphoma.

Reported associations

IgG N-glycosylation: This variant is associated with this GWAS, which tested 77 quantitative IgG glycan measures in a discovery cohort of 2,247 Europeans (P < 2.27 x 10^-9 significance threshold). The specific glycan trait and per-variant effect size are not detailed in the available study excerpt.
Autoimmune disease (locus overlap): The non-glycosyltransferase loci from this study overlap with genomic regions previously associated with systemic lupus erythematosus, rheumatoid arthritis, ulcerative colitis, Crohn's disease, type 1 diabetes, multiple sclerosis, Graves' disease, and celiac disease. The authors describe this as reflecting pleiotropy across the broader set of loci, not as a direct per-variant association.
Haematological cancers (locus overlap): Loci from this GWAS also overlap with regions previously associated with acute lymphoblastic leukaemia, Hodgkin lymphoma, and multiple myeloma. The authors suggest this overlap may explain why some loci show opposing effects across autoimmune disease and cancer contexts.

Evidence quality The source study is a well-powered GWAS using a combined sample of approximately 4,100 Europeans and two independent measurement technologies (UPLC and MALDI-TOF mass spectrometry), with a conservative genome-wide significance threshold of P < 2.27 x 10^-9. However, this variant is not named among the nine principal loci described in the study abstract (ST6GAL1, B4GALT1, FUT8, MGAT3, IKZF1, IL6ST-ANKRD55, ABCF2-SMARCD3, SUV420H1, SMARCB1-DERL3), and the full per-variant results tables are not available in the provided text excerpt. Consequently, the specific IgG glycan trait, effect size, p-value, and replication status for this locus cannot be confirmed from the available information. The autoimmune and cancer associations described above reflect locus-level overlaps noted for the broader GWAS findings, not confirmed direct associations for this variant specifically. This evidence should be considered preliminary.

Lifestyle considerations No lifestyle considerations on file for this variant.

Frequently asked questions

What is rs10971170 associated with?

rs10971170 is located in the Y_RNA-APTX region and was identified in a genome-wide association study of IgG antibody glycosylation, the process of attaching sugar chains to antibodies. The broader set of loci in this study overlaps with genes previously linked to autoimmune conditions and blood cancers, though specific data for this variant alone is limited.

What is IgG glycosylation and why does it matter?

IgG glycosylation refers to the attachment of sugar chains (glycans) to IgG antibodies. These sugar structures influence how antibodies interact with immune receptors, for example, the absence of galactose is linked to rheumatoid arthritis, and the addition of sialic acid can convert IgG from a pro-inflammatory to an anti-inflammatory signal.

What does the APTX gene do?

APTX encodes aprataxin, a protein involved in DNA repair. The rs10971170 variant sits in the genomic neighborhood of APTX and a small non-coding RNA element called Y_RNA, though the study providing this association does not describe a direct functional role for these elements in IgG glycosylation.

Is rs10971170 linked to autoimmune disease?

The study found that several genetic loci associated with IgG glycosylation overlap with regions previously linked to autoimmune diseases including lupus, rheumatoid arthritis, and multiple sclerosis. Whether this applies directly to this variant is not specified in the available study data.

How reliable is the evidence for rs10971170?

The source study used a large combined sample of roughly 4,100 Europeans and two independent laboratory methods with a strict significance threshold. However, this variant is not named among the principal loci in the study abstract, and per-variant data is not available from the provided text, so the strength of evidence for this specific variant is uncertain.

Expressive opens up early access